FeesSafety
Pluang+

iTonic shares plunge 95% amid pump-and-dump lawsuit over false Gilead acquisition rumors

Market News
17 Sep 2026, 17:07 WIB
PRNewsWire
View Source
Bearish
iTonic shares plunge 95% amid pump-and-dump lawsuit over false Gilead acquisition rumors

iTonic Holdings Ltd faces a class action lawsuit alleging a pump-and-dump scheme driven by fake rumors of a Gilead Sciences acquisition. The stock soared from $4 to nearly $31 before crashing 95% in one day after the company denied any acquisition talks. Investors claim they were not warned about the manipulation risks, and the lawsuit seeks compensation for losses during the spike and collapse. The lead plaintiff deadline is September 29, 2026.

iTonic Holdings Ltd faces a securities class action deadline on September 29, 2026. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Sep 17, 2026 20:41 WIB: out of 74 priced stocks, 56 rose and 17 fell. Notable movers include AGNC Investment Corp at USD 10.02 with a 1-day change of +1.42% and a typical hold time on Pluang of 102 days, Blackrock Inc at USD 1,050.83 with a +1.31% change and a 137-day hold time, and ARMOUR Residential REIT, Inc. at USD 15.00 with a +1.28% change and a 136-day hold time.

More News

Nova Klúbburinn completes share buyback, purchasing 122.7 million shares at ISK 3.26 each

Nova Klúbburinn completes share buyback, purchasing 122.7 million shares at ISK 3.26 each

Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...

Market News
Neutral
1 hour ago
DaVita faces securities fraud investigation after kidney care reform plan hits its stock.

DaVita faces securities fraud investigation after kidney care reform plan hits its stock.

Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a significant stock price drop triggered by a new federal kidney care strategy announced by the U.S. Department of Health and Human Services. The plan aims to increas...

Market News
Bearish
5 hours ago
3M commits $5.8B through 2034 to settle PFAS injury claims, cutting litigation risks significantly.

3M commits $5.8B through 2034 to settle PFAS injury claims, cutting litigation risks significantly.

3M has agreed to a $7.35 billion nominal settlement, with a present value of $5.8 billion, to resolve approximately 99% of PFAS-related personal injury claims involving up to 120,000 plaintiffs. This settlement reduces litigation uncertainty and alig...

Market News
Neutral
5 hours ago
Law firm probes Evolus over FDA warning on misleading Jeuveau ads, shares drop 7%.

Law firm probes Evolus over FDA warning on misleading Jeuveau ads, shares drop 7%.

Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the ads for minimizing safety risks and making exaggerated claims about th...

Market News
Bearish
5 hours ago
Neogen faces investigation after FDA links its sterile product to horse deaths, causing stock to drop 7%.

Neogen faces investigation after FDA links its sterile product to horse deaths, causing stock to drop 7%.

Pomerantz LLP is investigating Neogen Corporation following an FDA warning about its veterinary wound care product, Neogen Vet HYCOAT, which was linked to serious infections and at least 20 horse deaths. This represents the largest number of horse de...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App